Return to search

Arsenal Capital recruits Huff as industry and operating partner

Arsenal Capital Partners has named Michael Huff as an industry and operating partner. Previously, Huff worked at Citadel Plastic Holdings Inc where he most recently served as president and CEO.


NEW YORK, October 27, 2015 – Arsenal Capital Partners, a leading New York-based private equity firm that invests in middle market specialty industrials and healthcare companies, announced today that it has strengthened its team of Industry & Operations Partners with the addition of Michael Huff. Mr. Huff will work within the firm’s Specialty Industrials Group and is the firm’s 12th Industry & Operations Partner.

Mr. Huff’s extensive experience combines working in senior operating positions with large public companies, as well as serving as CEO for a global portfolio company of a mid-market private equity firm. Prior to joining Arsenal, Mr. Huff served with Citadel Plastic Holdings, Inc. since 2008, most recently as President and CEO for the past five years. He was with Johns Manville Corporation from 2003 to 2007 as a Vice President, Operations and more recently VP/General Manager. From 1982 to 2003 he served in increasing operational capacities for GE Plastics. He began his career with Diamond Shamrock. He is a graduate of Rose-Hulman Institute of Technology with a Bachelor of Science in Chemical Engineering.

John Televantos, a Partner who co-heads Arsenal’s Specialty Industrials group, said, “Arsenal invests in companies that have the potential for further value creation by accelerating growth and enhancing operational capabilities and competitiveness. We have over time built a diverse and dedicated team of world-class operating resources to help us grow our portfolio companies globally and we believe that Mike is an outstanding operating executive who will be able to apply the experience he has attained over the past 35+ years to our current and new investments.”

About Arsenal Capital Partners
Arsenal Capital Partners is a leading New York-based private equity firm that invests in lower middle market healthcare and specialty industrial companies. Arsenal makes investments in sectors where the firm has significant prior knowledge and experience. Arsenal targets businesses that have the potential for further value creation by working closely with management to accelerate growth and leverage the firm’s operational improvement capabilities. Arsenal currently has $1.7 billion of committed equity capital. For additional information on Arsenal Capital Partners, please visit

Arsenal’s Specialty Industrials investments includes several market leaders including Kel-Tech, a leading provider of specialty chemicals and related services to oil & gas exploration and production companies; Flowchem, a leading provider of patented and environmentally friendly drag reducing additive solutions and support services to crude oil and refined products pipeline operators; Accella Performance Materials, a leading manufacturer of formulated polyurethane, specialty coatings as well as recycled rubber products; Chromaflo Technologies, the largest independent global pigment dispersion provider to the architectural and industrial coatings and thermoset composites industries; Inhance Technologies, a leading provider of unique plastic barrier, adhesion and surface enhancement products and services as well as manufacturer of value-added materials; International Fiber Corporation, a leading provider of dietary insoluble fiber for food and pharmaceutical markets; and IGM Resins, a leading provider of intermediates to the global ultraviolet radiation cure coatings, inks and adhesives industry.